QA: UNITED THERAPEUTICS Corp in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001082554_2020_UNITED_THERAPEUTICS_Corp.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001082554, UNITED THERAPEUTICS Corp

  xvar xval
0 AssetsCurrent 1,864,500,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 738,500,000
3 remainder_Assets 1,310,400,000
4 LiabilitiesCurrent 463,000,000
5 LiabilitiesNoncurrent 70,000,000
6 remainder_Liabilities 600,000,000
7 CostOfGoodsAndServicesSold 117,600,000
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 1,182,600,000
10 remainder_Expenses 275,700,000
11 remainder_Revenues 1,448,800,000
12 remainder_NetIncome 22,600,000
13 remainder_ComprehensiveNetIncome -6,300,000
  yvar yval
0 Assets 3,913,400,000
1 Liabilities 1,133,000,000
2 Expenses 1,575,900,000
3 Revenues 1,448,800,000
4 StockholdersEquity 2,780,400,000
5 NetIncome -104,500,000
6 ComprehensiveNetIncome -107,650,000
7 BaseVar 4,050,000,000
8 EconomicCapitalRatio 1.85

Edgar->Model Mapping

Feature Distribution

Change over Time